Liver-on-a-chip is a type of organ-on-a-chip (OoC) technology [7] that replicates the functions of the human liver on a microfluidic chip. The liver-on-a-chip consists of a transparent polymer membrane that is lined with living liver cells, including hepatocytes and other supportive cells, and microchannels that simulate the blood flow and mechanical forces present in the liver.
The liver-on-a-chip technology aims to provide a more accurate and reliable platform for drug discovery, toxicity testing, and disease modeling for liver-related diseases such as hepatitis, cirrhosis, and liver cancer. Researchers can use the liver-on-a-chip technology to study the effects of various drugs, toxins, and diseases on liver function and disease development and to test the safety and efficacy of new drugs before human clinical trials.
Moreover, liver-on-a-chip technology has the potential to revolutionize the field of regenerative medicine. By creating a platform that mimics the structure and function of the liver, researchers can study the behavior of stem cells and other cell types in a microenvironment that is similar to liver tissue and develop new strategies for repairing damaged liver tissue or even creating new liver tissue for transplantation.
Report Highlights
Report Scope
By Company
Segment by Type
Segment by Application
Consumption by Region
Ìý Ìý North America
Ìý Ìý Europe
Ìý Ìý Asia-Pacific
Ìý Ìý Latin America
Ìý Ìý Middle East & Africa
Core Chapters
1 Liver-on-a-Chip Model Â鶹Դ´ Overview
1.1 Product Overview and Scope of Liver-on-a-Chip Model
1.2 Liver-on-a-Chip Model Segment by Type
1.2.1 Global Liver-on-a-Chip Model Â鶹Դ´ Value Comparison by Type (2023-2029)
1.2.2 Single-organ Systems
1.2.3 Multi-organ Systems
1.3 Liver-on-a-Chip Model Segment by Application
1.3.1 Global Liver-on-a-Chip Model Â鶹Դ´ Value by Application: (2023-2029)
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic Research Institutes
1.4 Global Liver-on-a-Chip Model Â鶹Դ´ Size Estimates and Forecasts
1.4.1 Global Liver-on-a-Chip Model Revenue 2018-2029
1.4.2 Global Liver-on-a-Chip Model Sales 2018-2029
1.4.3 Global Liver-on-a-Chip Model Â鶹Դ´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Liver-on-a-Chip Model Â鶹Դ´ Competition by Manufacturers
2.1 Global Liver-on-a-Chip Model Sales Â鶹Դ´ Share by Manufacturers (2018-2023)
2.2 Global Liver-on-a-Chip Model Revenue Â鶹Դ´ Share by Manufacturers (2018-2023)
2.3 Global Liver-on-a-Chip Model Average Price by Manufacturers (2018-2023)
2.4 Global Liver-on-a-Chip Model Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Liver-on-a-Chip Model, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liver-on-a-Chip Model, Product Type & Application
2.7 Liver-on-a-Chip Model Â鶹Դ´ Competitive Situation and Trends
2.7.1 Liver-on-a-Chip Model Â鶹Դ´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Liver-on-a-Chip Model Players Â鶹Դ´ Share by Revenue
2.7.3 Global Liver-on-a-Chip Model Â鶹Դ´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Liver-on-a-Chip Model Retrospective Â鶹Դ´ Scenario by Region
3.1 Global Liver-on-a-Chip Model Â鶹Դ´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Liver-on-a-Chip Model Global Liver-on-a-Chip Model Sales by Region: 2018-2029
3.2.1 Global Liver-on-a-Chip Model Sales by Region: 2018-2023
3.2.2 Global Liver-on-a-Chip Model Sales by Region: 2024-2029
3.3 Global Liver-on-a-Chip Model Global Liver-on-a-Chip Model Revenue by Region: 2018-2029
3.3.1 Global Liver-on-a-Chip Model Revenue by Region: 2018-2023
3.3.2 Global Liver-on-a-Chip Model Revenue by Region: 2024-2029
3.4 North America Liver-on-a-Chip Model Â鶹Դ´ Facts & Figures by Country
3.4.1 North America Liver-on-a-Chip Model Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Liver-on-a-Chip Model Sales by Country (2018-2029)
3.4.3 North America Liver-on-a-Chip Model Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Liver-on-a-Chip Model Â鶹Դ´ Facts & Figures by Country
3.5.1 Europe Liver-on-a-Chip Model Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Liver-on-a-Chip Model Sales by Country (2018-2029)
3.5.3 Europe Liver-on-a-Chip Model Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liver-on-a-Chip Model Â鶹Դ´ Facts & Figures by Country
3.6.1 Asia Pacific Liver-on-a-Chip Model Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Liver-on-a-Chip Model Sales by Country (2018-2029)
3.6.3 Asia Pacific Liver-on-a-Chip Model Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liver-on-a-Chip Model Â鶹Դ´ Facts & Figures by Country
3.7.1 Latin America Liver-on-a-Chip Model Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Liver-on-a-Chip Model Sales by Country (2018-2029)
3.7.3 Latin America Liver-on-a-Chip Model Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liver-on-a-Chip Model Â鶹Դ´ Facts & Figures by Country
3.8.1 Middle East and Africa Liver-on-a-Chip Model Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Liver-on-a-Chip Model Sales by Country (2018-2029)
3.8.3 Middle East and Africa Liver-on-a-Chip Model Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liver-on-a-Chip Model Sales by Type (2018-2029)
4.1.1 Global Liver-on-a-Chip Model Sales by Type (2018-2023)
4.1.2 Global Liver-on-a-Chip Model Sales by Type (2024-2029)
4.1.3 Global Liver-on-a-Chip Model Sales Â鶹Դ´ Share by Type (2018-2029)
4.2 Global Liver-on-a-Chip Model Revenue by Type (2018-2029)
4.2.1 Global Liver-on-a-Chip Model Revenue by Type (2018-2023)
4.2.2 Global Liver-on-a-Chip Model Revenue by Type (2024-2029)
4.2.3 Global Liver-on-a-Chip Model Revenue Â鶹Դ´ Share by Type (2018-2029)
4.3 Global Liver-on-a-Chip Model Price by Type (2018-2029)
5 Segment by Application
5.1 Global Liver-on-a-Chip Model Sales by Application (2018-2029)
5.1.1 Global Liver-on-a-Chip Model Sales by Application (2018-2023)
5.1.2 Global Liver-on-a-Chip Model Sales by Application (2024-2029)
5.1.3 Global Liver-on-a-Chip Model Sales Â鶹Դ´ Share by Application (2018-2029)
5.2 Global Liver-on-a-Chip Model Revenue by Application (2018-2029)
5.2.1 Global Liver-on-a-Chip Model Revenue by Application (2018-2023)
5.2.2 Global Liver-on-a-Chip Model Revenue by Application (2024-2029)
5.2.3 Global Liver-on-a-Chip Model Revenue Â鶹Դ´ Share by Application (2018-2029)
5.3 Global Liver-on-a-Chip Model Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Emulate
6.1.1 Emulate Corporation Information
6.1.2 Emulate Description and Business Overview
6.1.3 Emulate Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Emulate Liver-on-a-Chip Model Product Portfolio
6.1.5 Emulate Recent Developments/Updates
6.2 CN Bio Innovations
6.2.1 CN Bio Innovations Corporation Information
6.2.2 CN Bio Innovations Description and Business Overview
6.2.3 CN Bio Innovations Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CN Bio Innovations Liver-on-a-Chip Model Product Portfolio
6.2.5 CN Bio Innovations Recent Developments/Updates
6.3 TissUse
6.3.1 TissUse Corporation Information
6.3.2 TissUse Description and Business Overview
6.3.3 TissUse Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TissUse Liver-on-a-Chip Model Product Portfolio
6.3.5 TissUse Recent Developments/Updates
6.4 Hesperos
6.4.1 Hesperos Corporation Information
6.4.2 Hesperos Description and Business Overview
6.4.3 Hesperos Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hesperos Liver-on-a-Chip Model Product Portfolio
6.4.5 Hesperos Recent Developments/Updates
6.5 Mimetas
6.5.1 Mimetas Corporation Information
6.5.2 Mimetas Description and Business Overview
6.5.3 Mimetas Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mimetas Liver-on-a-Chip Model Product Portfolio
6.5.5 Mimetas Recent Developments/Updates
6.6 Micronit Microtechnologies B.V.
6.6.1 Micronit Microtechnologies B.V. Corporation Information
6.6.2 Micronit Microtechnologies B.V. Description and Business Overview
6.6.3 Micronit Microtechnologies B.V. Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Micronit Microtechnologies B.V. Liver-on-a-Chip Model Product Portfolio
6.6.5 Micronit Microtechnologies B.V. Recent Developments/Updates
6.7 Kirkstall
6.6.1 Kirkstall Corporation Information
6.6.2 Kirkstall Description and Business Overview
6.6.3 Kirkstall Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kirkstall Liver-on-a-Chip Model Product Portfolio
6.7.5 Kirkstall Recent Developments/Updates
6.8 Cherry Biotech SAS
6.8.1 Cherry Biotech SAS Corporation Information
6.8.2 Cherry Biotech SAS Description and Business Overview
6.8.3 Cherry Biotech SAS Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cherry Biotech SAS Liver-on-a-Chip Model Product Portfolio
6.8.5 Cherry Biotech SAS Recent Developments/Updates
6.9 Revivocell
6.9.1 Revivocell Corporation Information
6.9.2 Revivocell Description and Business Overview
6.9.3 Revivocell Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Revivocell Liver-on-a-Chip Model Product Portfolio
6.9.5 Revivocell Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liver-on-a-Chip Model Industry Chain Analysis
7.2 Liver-on-a-Chip Model Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liver-on-a-Chip Model Production Mode & Process
7.4 Liver-on-a-Chip Model Sales and Â鶹Դ´ing
7.4.1 Liver-on-a-Chip Model Sales Channels
7.4.2 Liver-on-a-Chip Model Distributors
7.5 Liver-on-a-Chip Model Customers
8 Liver-on-a-Chip Model Â鶹Դ´ Dynamics
8.1 Liver-on-a-Chip Model Industry Trends
8.2 Liver-on-a-Chip Model Â鶹Դ´ Drivers
8.3 Liver-on-a-Chip Model Â鶹Դ´ Challenges
8.4 Liver-on-a-Chip Model Â鶹Դ´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Â鶹Դ´ Size Estimation
10.1.3 Â鶹Դ´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Emulate
CN Bio Innovations
TissUse
Hesperos
Mimetas
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Revivocell
Ìý
Ìý
*If Applicable.
